Run-up to the American bioterrorist State’s Jan. 31, 2020 declaration of war - Part 1.
Timeline of executive orders, patents, papers, regulations, statutes, events
Bio-war on Americans was declared Jan. 31, 2020, by then-Secretary of Health and Human Services Alex Azar, effective Jan. 27, 2020. There are many more data points that could be included in this timeline; these are just the ones that happened in the immediate, five-year period between January 2014 and the outbreak as allegedly reported by China to WHO in December 2019 and declared in January 2020, that I currently have in my index card files and pulled out while digging online and reading documents.
Part 1 - January 2014 to December 2017 (below, published May 25, 2022, updated Aug. 10, 2022)
Part 2 - January 2018 to January 2020 (published June 3, 2022)
Part 1 - January 2014 to December 2017
2014/02/23 - US-led Maidan coup that began in November 2013, overthrew the Russia-aligned Yanukovych government of Ukraine, to install a government willing to enable US-Department of Defense/Health and Human Services bioweapons research in labs in Ukraine, and to create opportunity to shoot down Malaysia Airlines Flight 17.
2014/04/04 - Anthony Fauci published paper in Science, Immune activation with HIV vaccines: implications of the adenovirus vector experience, reporting that adenovirus vector vaccines for HIV increase recipients’ susceptibility to HIV infection.
2014/07/18 - Crash of Malaysia Airlines Flight 17 after missile strike launched from eastern Ukraine, killed 298 passengers, including 100 of the world’s most prominent AIDS researchers en route to a conference in Australia. The dead researchers were the people most likely to be able to understand and alert the world to government-run bioterrorism campaigns built by Anthony Fauci, Ralph Baric, Peter Daszak, and others, on the HIV-AIDS genetic base.
2014/07/31 - Executive Order 13674 signed by President Barack Obama. Added suspected, asymptomatic SARS [lab-manipulated human cold viruses] to list of communicable diseases subjecting American citizens to search, seizure and detention upon orders of Health and Human Services Secretary.
2014/08/19 - HHS published FDA Guidance: Decisions for Investigational Device Exemption Clinical Investigations by Center for Devices and Radiological Health and Center for Biologics Evaluation and Research. Loosened regulation of research protocols for new medical devices.
“Developed to facilitate the initiation of clinical investigations to evaluate medical devices…FDA approval of an IDE submission allows the initiation of subject enrollment in a clinical investigation of a significant risk device.”
2014/09 - Martin Gilens and Benjamin Page published paper in Perspectives on Politics, Testing Theories of American Politics: Elites, Interest Groups, and Average Citizens, concluding:
“Multivariate analysis indicates that economic elites and organized groups representing business interests have substantial independent impacts on U.S. government policy, while average citizens and mass-based interest groups have little or no independent influence.”
2014/10/17 - Obama White House and Health and Human Services Department National Institutes of Health Notice NOT-OD-15-011: Moratorium on federal funding for “certain types” of Gain-of-Function research “following safety breaches at federal institutions involving anthrax and avian flu.”
2015/04/15 - Journal of Neuroscience Methods, paper by Miranda et al, DARPA-funded efforts in the development of novel brain-computer interfaces. Part of entire journal issue on related topics.
2015/04/16 - US Congress passed Medicare Access and CHIP Reauthorization Act. (MACRA, PL 114-10). Largest change in health care system since ObamaCare Act in 2010. Section 511 directed HHS to clarify how changes to human subjects protections under 1991 Common Rule would apply to Medicare and Medicaid “clinical data registries.” Related to ‘real world evidence’ with no legal protections for human subjects, replacing traditional clinical trial procedures that did have legal protections for human subjects.
2015/07/23 - Erica Bickerton, Sarah Keep and Paul Britton of Pirbright Institute (UK) filed US patent application 2017/0216427, to patent their invention of
“a live, attenuated coronavirus comprising a variant replicate gene…that may be used as a vaccine for treating and/or preventing a disease, such as infectious bronchitis, in a subject.”
The patent — related to the infectious bronchitis virus that circulates among poultry — was granted 11/20/2018. Bickerton et al hold several related patents. This issue is connected to Johns Hopkins University Center for Health Security report Technologies to Address Global Catastrophic Biological Risks (10/09/2018) on ‘self-spreading vaccine’ technology, informed consent challenges of same, and ‘self-amplifying mRNA vaccines,’ and Major Joseph Murphy’s DARPA report (08/13/2021) on SARS-CoV-2 as a chimeric, lab-created, lab-released, de-attenuating virus.
“Shedding means release of virus or bacteria-based gene therapy (VGBT) products through one or all of the following ways: excreta (feces); secreta (urine, saliva, nasopharyngeal fluids etc.) or through the skin (pustules, sores, wounds). Shedding is distinct from bio distribution because the latter describes how a product is spread with the patient’s body from the site of administration while the former describes how it is excreted or released from the patient’s body. Shedding raises the possibility of transmission…from treated to untreated individuals (e.g. close contacts and health care professionals).” “Gene therapy products are all products that mediate their effects by transcription and/or translation of transferred material and/or by integrating it into the host genome and that are administered as nucleic acids, viruses, or genetically engineered microorganisms.”
2015/11/20 - Menachery, Baric, Shi et al published paper, A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence, in Nature Medicine.
The emergence of severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome (MERS)-CoV underscores the threat of cross-species transmission events leading to outbreaks in humans. Here we examine the disease potential of a SARS-like virus, SHC014-CoV, which is currently circulating in Chinese horseshoe bat populations. Using the SARS-CoV reverse genetics system, we generated and characterized a chimeric virus expressing the spike of bat coronavirus SHC014 in a mouse-adapted SARS-CoV backbone. The results indicate that group 2b viruses encoding the SHC014 spike in a wild-type backbone can efficiently use multiple orthologs of the SARS receptor human angiotensin converting enzyme II (ACE2), replicate efficiently in primary human airway cells and achieve in vitro titers equivalent to epidemic strains of SARS-CoV. Additionally, in vivo experiments demonstrate replication of the chimeric virus in mouse lung with notable pathogenesis. Evaluation of available SARS-based immune-therapeutic and prophylactic modalities revealed poor efficacy; both monoclonal antibody and vaccine approaches failed to neutralize and protect from infection with CoVs using the novel spike protein.
2015/11/25 - Congress passed 2016 National Defense Authorization Act. PL 114-92, 129 Stat. 893. Section 815 added the ‘prototype’ contracting language to Title 10, Military Law (10 USC 2371b, later renumbered 10 USC 4021), authorizing Department of Defense to contract with pharmaceutical corporations to conduct otherwise illegal medical experiments on the American and global public without notice or consent. First two posts on this topic: 05/25/2022 and 05/26/2022. [Section added 05/27/2022]
2016/02/04 - Moderna filed one US patent application for the genetic sequence of the furin cleavage site that later appeared in SARS-Cov-2. US9587003B2. (Moderna filed four other patents on related sequences on 12/16/2013). See Frontiers in Virology paper, 02/21/2022, Ambati et al, MSH3 Homology and potential recombination link to SARS-CoV-2 Furin cleavage site; DailyExpose.uk, 03/14/2022
2016/02/20 - Prepareforchange.net List of over 100 dead microbiologists.
2016/06/12 - Bill Gates and Klaus Schwab draft Coalition for Epidemic Preparedness Innovations (CEPI) business plan for presentation to World Health Organization.
2016/09/21 - HHS Clinical Trials Registration and Results Final Rule. Loosened human subjects protections and other regulation of research protocols for new drugs, devices and biologics.
2016/07/01 - President Barack Obama signed Executive Order 13732, US Policy on Pre- and Post-strike measures to address civilian casualties in US operations involving use of force. If I understand it correctly, it relates to the killing of American non-combatants, in areas outside of active hostility areas, in foreign countries and on American soil, with non-traditional weapons including drones and bioweapons.
2016/08/03 - Anthony Fauci and US Health and Human Services Department applied for US patent 9,896,509 (granted 02/20/2018) on gp120 glycoprotein from HIV, also found in SARS-Cov-2. See Igor Chudov Substack, 02/19/2022.
2016/11/04 - Executive Order 13747 signed by President Barack Obama: Advancing the Global Health Security Agenda to Achieve a World Safe and Secure from Infectious Disease Threats
2016/11/08 - Donald Trump elected president, surprising many. Russiagate enters high gear. Obama Administration enters lame duck period.
2016/12/13 - Congress passed and Obama signed 21st Century Cures Act (Cures Act 1.0) - PL 114-255. Updated and expanded Public Health Service Act, 42 USC 201, “to accelerate the discovery, development, and delivery of 21st century cures.” Provided (Section 3022) for ‘real world evidence’ instead of clinical trials as grounds for FDA authorizing general use of experimental products, transforming Americans into human subjects and our communities into unmonitored, unregulated experimental test sites. Provided (Section 3023 and 3024) broad authority for HHS Secretary to waive or alter human subject protections and informed consent requirements, by transferring each individual human subject’s risk-benefit assessment authority to the HHS Secretary, to preemptively decide, for all subjects collectively, without knowledge of individual health conditions or conscientious beliefs, and without the subjects’ knowledge or consent, that risk is ‘minimal.’ This statutory override of the individual right of informed consent was implemented through HHS Code of Federal Regulation (CFR) final rules published 01/19/2017, in full force 01/21/2019, and HHS Guidance for Sponsors, Investigators and Institutional Review Boards, published 07/25/2017.
2016/12/23 - Congress passed and President Obama signed 2017 National Defense Authorization Act - PL114-328. Established DOD Defense Security Cooperation Agency (DSCA) and Director of DSCA, with authority to coordinate and synchronize US military with foreign military forces, and conduct domestic military campaigns in violation of the 1878 Posse Comitatus Act. 10 USC 382. See 01/23/2017 Department of Homeland Security Biological Incident Annex to the Response and Recovery Federal Interagency Operational Plans at p. 70.
2017/01/09 - Health and Human Services, National Science Advisory Board for Biosecurity, and National Academies of Sciences, Engineering and Medicine announced new federal guidance on funding of gain-of-function “dual-use” research which had been suspended in October 2014. P3CO — Potential Pandemic Pathogens Care and Oversight program: Recommended Policy Guidance for Departmental Development of Review Mechanisms for Potential Pandemic Pathogen Care and Oversight, drafted after meetings held in May and June 2016.
2017/01/10 - President-elect Trump attempted to appoint Robert F. Kennedy Jr. to head the federal vaccine safety panel. Obama’s White House announced new legal frameworks for Gain-of-Function research. See University of Minnesota Center for Infectious Disease Research and Policy news feed.
2017/01/13 - HHS published FDA Guidance: Emergency Use Authorization of Medical Products and Related Authorities.
2017/01/19 - Bill Gates’ and Klaus Schwab’s Coalition for Epidemic Preparedness and Innovation (CEPI) formally launched at World Economic Forum, to provide a new, global, fast-track funding mechanism for vaccine research and development.
2017/01/19 - HHS published Federal Policy for the Protection of Human Subjects Final Rule. Joint rule by 16 federal agencies, subsequently adopted by other agencies. Reduced human subjects protections by revising 1991 Common Rule, which had been developed based on 1947 Nuremberg Code and 1978 Belmont Report.
2017/01/19 - HHS published HHS Control of Communicable Diseases Final Rule. Expanded HHS quarantine powers, expanded number and type of diseases classified as quarantinable, and therefore legal triggers for military apprehension and detention of American civilians.
2017/01/20 - President Trump inaugurated.
2017/01/23 - Department of Homeland Security published Biological Incident Annex to the Response and Recovery Federal Interagency Operational Plans, announcing HHS and DOD authority to task US military personnel with apprehension and detention of US civilians during biological incidents.
2017/07/25 - HHS published FDA Guidance for Sponsors, Investigators and Institutional Review Boards: IRB Waiver or Alteration of Informed Consent for Clinical Investigations Involving No More Than Minimal Risk to Human Subjects.
2017/08/31 - HHS published FDA Guidance: Use of Real-World Evidence to Support Regulatory Decision-Making for Medical Devices. Implemented Section 3022 of the 2016 21st Century Cures Act, establishing ‘real world evidence’ instead of clinical trials as grounds for the FDA to authorize general public use of experimental products, transforming Americans into human subjects and our communities into unmonitored, unregulated experimental test sites.
2017/09 - Katz et al published paper: Funding Public Health Emergency Preparedness in the United States in American Journal of Public Health.
2017/10 - Johns Hopkins University Center for Health Security exercise and report, SPARS Pandemic, 2025-2028, A Futuristic Scenario for Public Health Risk Communicators. Chapter 13 covered how government and corporate PR representatives should handle “anti-vaccine” messages. Chapter 17 covered how they should manage public awareness and anger about vaccine injury.
2017/12/12 - Act to amend FDCA EUA statute, 21 USC 360bbb-3. PL 115-92, 131 Stat. 2023. (3 pages). Provided for “Additional Emergency Uses for Medical Products to Reduce Deaths and Severity of Injuries Caused by Agents of War”
2017/12/19 - Trump White House and Health and Human Services Department National Institutes of Health Notice NOT-OD-17-071, announced lifting of October 2014 moratorium on federal funding for gain-of-function/dual-use research and new Framework for Guiding Funding Decisions About Proposed Research Involving Enhanced Potential Pandemic Pathogens. The new framework superseded the February 2013 guidance: A Framework for Guiding U.S. Department of Health and Human Services Funding Decisions about Research Proposals with the Potential for Generating Highly Pathogenic Avian Influenza H5N1 Viruses that are Transmissible among Mammals by Respiratory Droplets. See University of Minnesota Center for Infectious Disease Research and Policy news feed.